AlanPollackMD

Radiation Oncology • Miami, FL

Professor of Radiation Oncology, University Miami School of Medicine

Join to view full profile

Dr. Pollack is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pollack's full profile

Already have an account?

Office
1475 Nw 12th Ave
Suite 1500
Miami, FL 33136
Phone+1 305-243-4916

Fax+1 305-243-4363

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1988 - 1992
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1987 - 1988
University of Miami Leonard M. Miller School of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 2008 - 2027
PA State Medical License 1991 - 2008
TX State Medical License 1992 - 2002
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Start of enrollment: 2011 Dec 27
Completed
Not Applicable
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31
Completed
Not Applicable
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
Active, not recruiting
Not Applicable
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer Start of enrollment: 2013 Apr 04
Recruiting
Not Applicable
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors Start of enrollment: 2011 Jun 08
Completed
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
Terminated
Not Applicable
MRI Based Active Selection for Treatment Trial Start of enrollment: 2014 Nov 12
Active, not recruiting
Not Applicable
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy Start of enrollment: 2015 Feb 05
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Isabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary
Academic Radiology. 2024-12-17
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial.
Tarek Ajami, Hui Yu, Joao G Porto, Nachiketh Soodana Prakash, Adam Williams
European Urology Focus. 2024-12-10
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra
European Urology Oncology. 2024-11-13

Press Mentions

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU SymposiumFebruary 11th, 2025
Three Junior Faculty Members Join Sylvester Comprehensive Cancer Center’s K12 Faculty Scholars at Annual SymposiumJuly 25th, 2024
Sylvester Junior Faculty Selected for K12 Research GrantsMay 16th, 2023
Join now to see all